Amgen lost an attempt to escape a potential class action claiming the pharmaceutical giant hid a $10.7 billion tax bill from investors after a New York federal court ruled there was sufficient evidence for the action to proceed.
Amgen Must Face Suit It Misled Investors On $10.7B Tax Bill
by usoftax_admin | Oct 1, 2024 | Tax News